New Breakthroughs in Fusion Energy and Cancer Treatment
核融合能源與癌症治療的重大突破
更新於: 2026年9月8日 上午03:30
In a remarkable display of serendipitous science, technologies originally engineered to unlock fusion energy are finding a second life in the fight against cancer.
在一場出人意料的機緣巧合中，原本為了解鎖核融合能量而研發的技術，正在抗癌領域中重獲新生。
This dual-use innovation shows how breakthroughs in nuclear physics can revolutionize medical care.
這種「雙重用途創新」展示了核物理學的突破如何能夠革命性地改變醫療照護。
Fusion research requires high-intensity particle beams to stabilize plasma.
核融合研究需要高強度粒子束來穩定電漿。
Scientists realized that these exact systems could be adapted for Boron Neutron Capture Therapy (BNCT), a precise treatment that targets tumor cells while sparing healthy tissue.
科學家發現，這些系統恰好可以改良用於「硼中子捕獲治療」(BNCT)，這是一種精準治療方式，能夠瞄準腫瘤細胞並避開健康組織。
By miniaturizing these bulky accelerators, researchers are working to bring this formerly inaccessible 'cellular surgery' into mainstream hospital settings.
透過將這些笨重的加速器微型化，研究人員正努力將這項過去難以取得的「細胞手術」引進主流醫院環境。
Simultaneously, 2026 has been a pivotal year for fusion, marked by the integration of AI like the PACMAN framework to stabilize plasma in milliseconds and the use of high-temperature superconducting magnets to increase efficiency.
與此同時，2026年對核融合而言是關鍵的一年，其標誌性事件包括結合如PACMAN架構等人工智慧，以在毫秒之間穩定電漿，以及使用高溫超導磁鐵來提升效率。
While these advancements bring us closer to clean, limitless power, their immediate medical spin-offs are equally transformative.
雖然這些進步使我們離清潔、無限的能源更近一步，但其即時的醫療衍生應用也同樣具有變革意義。
From personalized mRNA vaccines to protein-degrading therapies, the intersection of energy engineering and oncology is creating a new era of precision.
從個人化mRNA疫苗到蛋白質降解療法，能源工程與腫瘤學的交會正在開創一個精準的新時代。
By repurposing sophisticated sensors and control algorithms, the fusion industry is doing more than powering the future; it is helping to save lives today.
透過轉換尖端感測器和控制演算法的用途，核融合產業做到的不僅是為未來提供動力；它還在幫助挽救當下的生命。
